Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.
NCT00002139 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To compare the uptake of azithromycin in white cells relative to plasma concentrations in HIV-infected patients.
Conditions
- Bacterial Infections
- HIV Infections
Interventions
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients
NCT00000947 ·Status: COMPLETED ·Phase: NA
-
Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048
NCT00000933 ·Status: COMPLETED
-
The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients
NCT00002336 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex
NCT00001011 ·Status: COMPLETED ·Phase: PHASE3
-
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
NCT00002267 ·Status: COMPLETED ·Phase: NA
-
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
NCT00002032 ·Status: COMPLETED ·Phase: NA
-
A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.
NCT00000641 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of Z-100 in Patients With Early HIV Infection
NCT00016692 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89
NCT00002141 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment
NCT00002334 ·Status: COMPLETED ·Phase: PHASE3
-
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study
NCT00002080 ·Status: COMPLETED ·Phase: NA
-
Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.
NCT00002192 ·Status: COMPLETED ·Phase: PHASE2
-
A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS
NCT00001995 ·Status: COMPLETED ·Phase: NA
-
A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients
NCT00002122 ·Status: COMPLETED ·Phase: PHASE3
-
Azithromycin/Bicillin Syphilis
NCT00031499 ·Status: COMPLETED ·Phase: PHASE3
-
Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study
NCT00002082 ·Status: COMPLETED ·Phase: NA
-
B/F/TAF Ease of Swallowability Trial
NCT04600687 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Rifampicin Capsules (RIF)
NCT07002255 ·Status: COMPLETED ·Phase: PHASE1
-
A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP
NCT00000700 ·Status: COMPLETED ·Phase: PHASE3
-
A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides
NCT00002114 ·Status: COMPLETED ·Phase: PHASE2
-
An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2
NCT00002023 ·Status: COMPLETED ·Phase: NA
-
A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.
NCT00002097 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Zidovudine in HIV-Infected Patients With Liver Disease
NCT00001001 ·Status: COMPLETED ·Phase: NA
-
A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection
NCT00000823 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of STI-1558 in Healthy Adults and SARS-CoV-2-Positive Patients
NCT05523739 ·Status: COMPLETED ·Phase: PHASE1